VAZQUEZ CHRIS (Chief Accounting Officer) sold 7.2% of their position (83.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $676.39 — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2026ACC: 0000905148-26-000253
Officer· Chief Accounting Officer
Since Feb 2026
-83.00
Net shares
Net seller
$676.39
Total sold
1
Open market trades
0B · 1S
3
Total transactions
219.00 acquired · 302.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+219.00
Price / share
—
Trade value
—
% of position
23.4%
1/15/2026
936.00→1.16K
Common Stock
Direct
Shares
−83.00
Price / share
$8.15
Trade value
$676.39
% of position
7.2%
1/16/2026
1.16K→1.07K
Total
Net shares
+136.00
Net value
-$676.39
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2026 | M · Option Exercise | +219.00 | — | — | 23.4% | 936.00 | 1.16K |
| Common Stock Direct | 1/16/2026 | S · Sale | −83.00 | $8.15 | $676.39 | 7.2% | 1.16K | 1.07K |
| Total | +136.00 | -$676.39 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
219.00 shares
Shares
−219.00
Strike price
Held after
436.00
Exercisable
—
1/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock219.00 shares | 1/15/2026 | M · Option Exercise | −219.00 | — | 436.00 |